Skip to main content

Table 6 Alterations in hematological parameters in CFA-induced inflammation in rats

From: Effect of new polyherbal formulations DF1911, DF2112 and DF2813 on CFA induced inflammation in rat model

Groups

Haemoglobin (gm %)

RBC (106/uL)

WBC total count (103/cumm)

ESR (mm/h)

HC

13.3 ± 0.23&&&

7.82 ± 0.24**

5.07 ± 0.32

0.5 ± 0.29

NC

12.9 ± 0.18&&

6.19 ± 0.45##&&&

10.9 ± 1.77

1 ± 0.41

Diclo

10.38 ± 0.71###**$

7.9 ± 0.2***

7.54 ± 0.92

0.5 ± 0.29

Dasha

12.4 ± 0.48&

7.16 ± 0.19

6.27 ± 1.15

0.75 ± 0.25

DF1911-LD

13.73 ± 0.12&&&

8.12 ± 0.22***

6.65 ± 2.54

1.25 ± 0.25

DF1911-MD

13.95 ± 0.39&&&

8.09 ± 0.15***

5.01 ± 2.71

0.5 ± 0.29

DF1911-HD

12.75 ± 0.9&&

7.36 ± 0.54*

8.99 ± 2.6

1.25 ± 0.25

DF2112-LD

14.25 ± 0.18&&&$

8.27 ± 0.06***$

7.8 ± 2.94

0.5 ± 0.29

DF2112-MD

14.03 ± 0.39&&&

8.31 ± 0.24***$

6.1 ± 0.53

0.75 ± 0.25

DF2112-HD

14.05 ± 0.45&&&

8.32 ± 0.32***$

5.55 ± 2.85

0.5 ± 0.29

DF2813-LD

14.43 ± 0.39&&&$

8.27 ± 0.16***$

6.03 ± 1.42

0.75 ± 0.25

DF2813-MD

14.15 ± 0.18&&&

8.31 ± 0.07***$

7.4 ± 0.82

0.75 ± 0.25

DF2813-HD

14.08 ± 0.23&&&

8.27 ± 0.09***$

6.01 ± 0.23

0.75 ± 0.25

  1. HC healthy control, NC negative control, Diclo diclofenac sodium, Dasha Dashamoola Kwatha, DF Dashamoola formulation, LD lower dose, MD middle dose, HD higher dose. Values are expressed as Mean ± SEM; n = 6. Data were analysed by One-Way ANOVA followed by Dunnett’s multiple comparison test. ## = p < 0.01, ### = p < 0.001 when compared to HC; * = p < 0.05, ** = p < 0.01, *** = p < 0.001 when compared to NC; & = p < 0.05, && = p < 0.01, &&& = p < 0.001 when compared to Diclo; $ = p < 0.05 when compared to Dasha